Back
Apogee Therapeutics, Inc. 10K Form
Sell
44
APGE
Apogee Therapeutics, Inc.
Last Price:
$84.40
Seasonality Move:
-11.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive APGE News And Ratings
See the #1 stock for the next 7 days that we like better than APGE
APGE Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-62.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $13.21 |
| Price / Book: | 6.44 |
Profitability
| EPS (TTM): | -4.21490 |
|---|---|
| Net Income (TTM): | $-255.8M |
| Gross Margin: | $-1.4M |
| Return on Equity: | -36.55% |
| Return on Assets: | -34.68% |
Apogee Therapeutics, Inc. Earnings Forecast
Key Apogee Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 4 years have been positive in 0 years.
Apogee Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | APGE |
| Website: | apogeetherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 26.57 |
| Quick Ratio: | 26.17 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
APGE Technical Analysis vs Fundamental Analysis
Sell
44
Apogee Therapeutics, Inc. (APGE)
is a Sell
Is Apogee Therapeutics, Inc. a Buy or a Sell?
-
Apogee Therapeutics, Inc. stock is rated a SellThe current Apogee Therapeutics, Inc. [APGE] share price is $84.34. The Score for APGE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.